publication venue for
- Targeting oncogenic BRAF in human cancer.. 355. 2012
- Different biological effects of c-myc and H-ras oncogene expression in EBV-infected human lymphoblasts.. 141. 1988
- Immunological probes in the analysis of myc protein expression.. 141. 1988
- Mining the Complex Family of Protein Tyrosine Phosphatases for Checkpoint Regulators in Immunity.. 410. 2017
- Cancer drug development. Preface.. 355. 2012
- Molecular mimicry: anti-DNA antibodies bind microbial and nonnucleic acid self-antigens. 2005
- Adjuvants. 2020
- Animal models for hepatitis C. 2013
- Innate immune responses to hepatitis C virus. 2013
- JAK-mutant myeloproliferative neoplasms. 2012
- Will kinase inhibitors make it as glioblastoma drugs? 2012
- Angiogenesis and the tumor vasculature as antitumor immune modulators: the role of vascular endothelial growth factor and endothelin. 2011
- NF-κB as a target for oncogenic viruses. 2011
- Kaposi sarcoma-associated herpesvirus and other viruses in human lymphomagenesis. 2007
- Monoclonal antibody therapy of APL. 2007
- Targeting APL fusion proteins by peptide interference. 2007
- Type I interferon in systemic lupus erythematosus. 2007
- Mechanisms of virus neutralization by antibody. 2001
- Diphtheria toxin fusion proteins. 1998
- Stress-induced proteins in immune response to cancer. 1991
- The fibroblast growth factors: an emerging family of neural growth factors. 1991